"STUDYID","USUBJID","AESEQ","TRTP","TRTPN","AETERM","AEDECOD","AEBODSYS","AECAT","AESEV","AETOXGR","ATOXGRN","AESER","AEREL","RELGR1","RELGR1N","ASTDT","AENDT","ASTDY","AENDY","ADURN","ADURU","TRTEMFL","AOCCFL","AOCC01FL","AOCCPFL","CQ01NAM","CQ02NAM","AGE","AGEGR1","SEX","MMSETOT","SAFFL"
"CDISCPILOT01","01-701-001",1,"Xanomeline Low Dose",1,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-06-23,2013-07-14,5,26,22,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,70,"65-80","F",21,"Y"
"CDISCPILOT01","01-701-001",2,"Xanomeline Low Dose",1,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-07-24,2013-08-14,36,57,22,"DAY","Y","Y","Y",NA,NA,NA,70,"65-80","F",21,"Y"
"CDISCPILOT01","01-701-001",3,"Xanomeline Low Dose",1,"Nasopharyngitis","Nasopharyngitis","Infections and infestations","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-07-29,2013-08-14,41,57,17,"DAY","Y","Y","Y",NA,NA,NA,70,"65-80","F",21,"Y"
"CDISCPILOT01","01-701-002",2,"Xanomeline Low Dose",1,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-04-29,2013-05-07,29,37,9,"DAY","Y","Y","Y",NA,NA,NA,68,"65-80","F",19,"Y"
"CDISCPILOT01","01-701-002",1,"Xanomeline Low Dose",1,"Skin irritation","Skin irritation","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-06-09,2013-07-03,70,94,25,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",68,"65-80","F",19,"Y"
"CDISCPILOT01","01-701-002",3,"Xanomeline Low Dose",1,"Syncope","Syncope","Nervous system disorders","GENERAL","SEVERE",3,3,"Y","NOT RELATED","N",0,2013-04-04,2013-04-11,4,11,8,"DAY","Y","Y",NA,"Y",NA,NA,68,"65-80","F",19,"Y"
"CDISCPILOT01","01-701-004",1,"Xanomeline High Dose",2,"Nasopharyngitis","Nasopharyngitis","Infections and infestations","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-11-16,2013-12-12,84,110,27,"DAY","Y","Y","Y",NA,NA,NA,87,">80","F",24,"Y"
"CDISCPILOT01","01-701-005",1,"Placebo",0,"Vomiting","Vomiting","Gastrointestinal disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-02-21,2013-03-25,14,46,33,"DAY","Y","Y","Y",NA,NA,NA,89,">80","F",18,"Y"
"CDISCPILOT01","01-701-006",1,"Placebo",0,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-08-18,2013-09-05,52,70,19,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",76,"65-80","F",14,"Y"
"CDISCPILOT01","01-701-006",3,"Placebo",0,"Upper respiratory tract infection","Upper respiratory tract infection","Infections and infestations","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-07-28,2013-08-19,31,53,23,"DAY","Y","Y","Y",NA,NA,NA,76,"65-80","F",14,"Y"
"CDISCPILOT01","01-701-006",2,"Placebo",0,"Vomiting","Vomiting","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-07-22,2013-08-01,25,35,11,"DAY","Y","Y","Y",NA,NA,NA,76,"65-80","F",14,"Y"
"CDISCPILOT01","01-701-007",1,"Placebo",0,"Cough","Cough","Respiratory, thoracic and mediastinal disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-07-21,2013-07-23,5,7,3,"DAY","Y","Y","Y",NA,NA,NA,65,"65-80","F",22,"Y"
"CDISCPILOT01","01-701-008",2,"Xanomeline Low Dose",1,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-12-02,2013-12-16,8,22,15,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,76,"65-80","M",13,"Y"
"CDISCPILOT01","01-701-008",1,"Xanomeline Low Dose",1,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-12-11,2013-12-21,17,27,11,"DAY","Y","Y",NA,NA,"APPLICATION SITE REACTION",NA,76,"65-80","M",13,"Y"
"CDISCPILOT01","01-701-008",4,"Xanomeline Low Dose",1,"Fatigue","Fatigue","General disorders and administration site conditions","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-11-30,2013-12-16,6,22,17,"DAY","Y","Y",NA,NA,NA,NA,76,"65-80","M",13,"Y"
"CDISCPILOT01","01-701-008",3,"Xanomeline Low Dose",1,"Headache","Headache","Nervous system disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2014-03-05,2014-03-20,101,116,16,"DAY","Y","Y","Y",NA,NA,NA,76,"65-80","M",13,"Y"
"CDISCPILOT01","01-701-010",2,"Xanomeline Low Dose",1,"Application site dermatitis","Application site dermatitis","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-12-31,2014-01-13,28,41,14,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,59,"<65","M",20,"Y"
"CDISCPILOT01","01-701-010",1,"Xanomeline Low Dose",1,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-12-10,2013-12-19,7,16,10,"DAY","Y","Y",NA,NA,"APPLICATION SITE REACTION",NA,59,"<65","M",20,"Y"
"CDISCPILOT01","01-701-010",4,"Xanomeline Low Dose",1,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2014-02-20,2014-04-01,79,119,41,"DAY","Y","Y","Y",NA,NA,NA,59,"<65","M",20,"Y"
"CDISCPILOT01","01-701-010",5,"Xanomeline Low Dose",1,"Headache","Headache","Nervous system disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2014-01-22,2014-02-04,50,63,14,"DAY","Y","Y",NA,NA,NA,NA,59,"<65","M",20,"Y"
"CDISCPILOT01","01-701-010",3,"Xanomeline Low Dose",1,"Skin irritation","Skin irritation","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2014-01-11,2014-02-04,39,63,25,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",59,"<65","M",20,"Y"
"CDISCPILOT01","01-701-011",1,"Xanomeline High Dose",2,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-09-24,2013-09-27,54,57,4,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",76,"65-80","F",17,"Y"
"CDISCPILOT01","01-701-012",1,"Placebo",0,"Somnolence","Somnolence","Nervous system disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-04-01,2013-04-14,23,36,14,"DAY","Y","Y","Y",NA,NA,NA,67,"65-80","M",22,"Y"
"CDISCPILOT01","01-701-013",2,"Xanomeline High Dose",2,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2014-01-07,2014-02-09,77,110,34,"DAY","Y","Y","Y",NA,NA,NA,79,"65-80","F",15,"Y"
"CDISCPILOT01","01-701-013",3,"Xanomeline High Dose",2,"Nasopharyngitis","Nasopharyngitis","Infections and infestations","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-12-29,2014-01-24,68,94,27,"DAY","Y","Y","Y",NA,NA,NA,79,"65-80","F",15,"Y"
"CDISCPILOT01","01-701-013",1,"Xanomeline High Dose",2,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-11-08,2013-12-02,17,41,25,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",79,"65-80","F",15,"Y"
"CDISCPILOT01","01-701-014",1,"Xanomeline Low Dose",1,"Application site dermatitis","Application site dermatitis","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-12-17,2013-12-31,9,23,15,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,79,"65-80","F",16,"Y"
"CDISCPILOT01","01-701-015",1,"Placebo",0,"Nasopharyngitis","Nasopharyngitis","Infections and infestations","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-07-20,2013-08-23,19,53,35,"DAY","Y","Y","Y",NA,NA,NA,80,">80","M",22,"Y"
"CDISCPILOT01","01-701-016",1,"Xanomeline High Dose",2,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"Y","POSSIBLY RELATED","Y",1,2013-10-01,2013-10-13,17,29,13,"DAY","Y","Y","Y","Y",NA,"DERMATOLOGICAL AE",63,"<65","F",14,"Y"
"CDISCPILOT01","01-701-017",1,"Placebo",0,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-07-20,2013-07-31,52,63,12,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",71,"65-80","F",16,"Y"
"CDISCPILOT01","01-701-018",2,"Placebo",0,"Headache","Headache","Nervous system disorders","GENERAL","LIFE-THREATENING",4,4,"Y","POSSIBLY RELATED","Y",1,2013-06-25,2013-07-05,72,82,11,"DAY","Y","Y","Y","Y",NA,NA,69,"65-80","F",14,"Y"
"CDISCPILOT01","01-701-018",1,"Placebo",0,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-07-11,2013-07-20,88,97,10,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",69,"65-80","F",14,"Y"
"CDISCPILOT01","01-701-020",1,"Xanomeline Low Dose",1,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-04-13,2013-04-16,3,6,4,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,73,"65-80","F",15,"Y"
"CDISCPILOT01","01-701-021",1,"Placebo",0,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-06-10,2013-06-18,58,66,9,"DAY","Y","Y","Y",NA,NA,NA,62,"<65","M",18,"Y"
"CDISCPILOT01","01-701-022",1,"Xanomeline High Dose",2,"Application site irritation","Application site irritation","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-10-14,2013-10-20,14,20,7,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,82,">80","F",19,"Y"
"CDISCPILOT01","01-701-022",2,"Xanomeline High Dose",2,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-11-07,2013-11-13,38,44,7,"DAY","Y","Y","Y",NA,NA,NA,82,">80","F",19,"Y"
"CDISCPILOT01","01-701-022",3,"Xanomeline High Dose",2,"Nasal congestion","Nasal congestion","Respiratory, thoracic and mediastinal disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-12-01,2013-12-24,62,85,24,"DAY","Y","Y","Y",NA,NA,NA,82,">80","F",19,"Y"
"CDISCPILOT01","01-701-023",1,"Xanomeline High Dose",2,"Application site irritation","Application site irritation","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-07-29,2013-08-05,3,10,8,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,73,"65-80","M",23,"Y"
"CDISCPILOT01","01-701-023",2,"Xanomeline High Dose",2,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-08-30,2013-09-04,35,40,6,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",73,"65-80","M",23,"Y"
"CDISCPILOT01","01-701-024",1,"Placebo",0,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","SEVERE",3,3,"Y","RELATED","Y",1,2014-01-09,2014-01-16,20,27,8,"DAY","Y","Y","Y","Y","APPLICATION SITE REACTION",NA,83,">80","M",15,"Y"
"CDISCPILOT01","01-701-024",2,"Placebo",0,"Upper respiratory tract infection","Upper respiratory tract infection","Infections and infestations","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2014-02-04,2014-02-26,46,68,23,"DAY","Y","Y","Y",NA,NA,NA,83,">80","M",15,"Y"
"CDISCPILOT01","01-701-026",3,"Xanomeline Low Dose",1,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-05-11,2013-05-21,66,76,11,"DAY","Y","Y","Y",NA,NA,NA,84,">80","F",10,"Y"
"CDISCPILOT01","01-701-026",2,"Xanomeline Low Dose",1,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-03-28,2013-04-06,22,31,10,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",84,">80","F",10,"Y"
"CDISCPILOT01","01-701-026",1,"Xanomeline Low Dose",1,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-05-14,2013-05-21,69,76,8,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",84,">80","F",10,"Y"
"CDISCPILOT01","01-701-027",1,"Xanomeline High Dose",2,"Nasopharyngitis","Nasopharyngitis","Infections and infestations","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2014-01-08,2014-02-05,41,69,29,"DAY","Y","Y","Y",NA,NA,NA,83,">80","M",14,"Y"
"CDISCPILOT01","01-701-028",1,"Xanomeline High Dose",2,"Application site irritation","Application site irritation","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-08-20,2013-09-03,24,38,15,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,68,"65-80","F",24,"Y"
"CDISCPILOT01","01-701-028",4,"Xanomeline High Dose",2,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-08-24,2013-08-24,28,28,1,"DAY","Y","Y","Y",NA,NA,NA,68,"65-80","F",24,"Y"
"CDISCPILOT01","01-701-028",3,"Xanomeline High Dose",2,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-08-16,2013-09-12,20,47,28,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",68,"65-80","F",24,"Y"
"CDISCPILOT01","01-701-028",5,"Xanomeline High Dose",2,"Nausea","Nausea","Gastrointestinal disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-08-20,2013-10-08,24,73,50,"DAY","Y","Y","Y",NA,NA,NA,68,"65-80","F",24,"Y"
"CDISCPILOT01","01-701-028",2,"Xanomeline High Dose",2,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-08-11,2013-08-25,15,29,15,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",68,"65-80","F",24,"Y"
"CDISCPILOT01","01-701-028",6,"Xanomeline High Dose",2,"Sinus bradycardia","Sinus bradycardia","Cardiac disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-08-11,2013-08-30,15,34,20,"DAY","Y","Y","Y",NA,NA,NA,68,"65-80","F",24,"Y"
"CDISCPILOT01","01-701-029",1,"Xanomeline High Dose",2,"Upper respiratory tract infection","Upper respiratory tract infection","Infections and infestations","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-12-03,2013-12-19,35,51,17,"DAY","Y","Y","Y",NA,NA,NA,74,"65-80","F",19,"Y"
"CDISCPILOT01","01-701-030",3,"Xanomeline Low Dose",1,"Confusional state","Confusional state","Psychiatric disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-07-27,2013-08-09,27,40,14,"DAY","Y","Y","Y",NA,NA,NA,72,"65-80","F",14,"Y"
"CDISCPILOT01","01-701-030",1,"Xanomeline Low Dose",1,"Headache","Headache","Nervous system disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-08-07,2013-08-18,38,49,12,"DAY","Y","Y","Y",NA,NA,NA,72,"65-80","F",14,"Y"
"CDISCPILOT01","01-701-030",2,"Xanomeline Low Dose",1,"Sinus bradycardia","Sinus bradycardia","Cardiac disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-07-07,2013-07-22,7,22,16,"DAY","Y","Y","Y",NA,NA,NA,72,"65-80","F",14,"Y"
"CDISCPILOT01","01-701-031",1,"Xanomeline High Dose",2,"Nausea","Nausea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-10-14,2013-11-03,28,48,21,"DAY","Y","Y","Y",NA,NA,NA,79,"65-80","F",23,"Y"
"CDISCPILOT01","01-701-034",1,"Xanomeline Low Dose",1,"Hyperhidrosis","Hyperhidrosis","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-09-11,2013-10-28,27,74,48,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",83,">80","F",15,"Y"
"CDISCPILOT01","01-701-034",2,"Xanomeline Low Dose",1,"Myocardial infarction","Myocardial infarction","Cardiac disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-09-11,2013-10-24,27,70,44,"DAY","Y","Y","Y",NA,NA,NA,83,">80","F",15,"Y"
"CDISCPILOT01","01-701-035",3,"Xanomeline High Dose",2,"Cough","Cough","Respiratory, thoracic and mediastinal disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-06-13,2013-07-01,49,67,19,"DAY","Y","Y","Y",NA,NA,NA,79,"65-80","F",12,"Y"
"CDISCPILOT01","01-701-035",4,"Xanomeline High Dose",2,"Fatigue","Fatigue","General disorders and administration site conditions","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-06-01,2013-07-01,37,67,31,"DAY","Y","Y","Y",NA,NA,NA,79,"65-80","F",12,"Y"
"CDISCPILOT01","01-701-035",1,"Xanomeline High Dose",2,"Rash","Rash","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-06-13,2013-06-26,49,62,14,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",79,"65-80","F",12,"Y"
"CDISCPILOT01","01-701-035",2,"Xanomeline High Dose",2,"Sinus bradycardia","Sinus bradycardia","Cardiac disorders","GENERAL","SEVERE",3,3,"Y","POSSIBLY RELATED","Y",1,2013-06-04,2013-06-25,40,61,22,"DAY","Y","Y","Y","Y",NA,NA,79,"65-80","F",12,"Y"
"CDISCPILOT01","01-701-036",1,"Xanomeline Low Dose",1,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-08-29,2013-09-04,13,19,7,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,76,"65-80","F",21,"Y"
"CDISCPILOT01","01-701-037",1,"Xanomeline Low Dose",1,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-01-22,2013-01-25,17,20,4,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,70,"65-80","M",24,"Y"
"CDISCPILOT01","01-701-037",2,"Xanomeline Low Dose",1,"Sinus bradycardia","Sinus bradycardia","Cardiac disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-02-28,2013-03-17,54,71,18,"DAY","Y","Y","Y",NA,NA,NA,70,"65-80","M",24,"Y"
"CDISCPILOT01","01-701-038",1,"Xanomeline High Dose",2,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-06-27,2013-06-30,13,16,4,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,68,"65-80","M",20,"Y"
"CDISCPILOT01","01-701-040",1,"Xanomeline Low Dose",1,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","SEVERE",3,3,"Y","NOT RELATED","N",0,2013-10-30,2013-11-19,27,47,21,"DAY","Y","Y","Y","Y",NA,"DERMATOLOGICAL AE",82,">80","F",17,"Y"
"CDISCPILOT01","01-701-041",1,"Xanomeline High Dose",2,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-11-19,2013-11-23,13,17,5,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,64,"<65","M",14,"Y"
"CDISCPILOT01","01-701-041",2,"Xanomeline High Dose",2,"Application site vesicles","Application site vesicles","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-11-15,2013-12-05,9,29,21,"DAY","Y","Y",NA,NA,"APPLICATION SITE REACTION",NA,64,"<65","M",14,"Y"
"CDISCPILOT01","01-701-042",1,"Placebo",0,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-09-13,2013-09-15,10,12,3,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,72,"65-80","M",13,"Y"
"CDISCPILOT01","01-701-042",2,"Placebo",0,"Somnolence","Somnolence","Nervous system disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-09-18,2013-10-13,15,40,26,"DAY","Y","Y","Y",NA,NA,NA,72,"65-80","M",13,"Y"
"CDISCPILOT01","01-703-001",1,"Placebo",0,"Application site vesicles","Application site vesicles","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-01-28,2013-02-19,16,38,23,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,70,"65-80","M",21,"Y"
"CDISCPILOT01","01-703-002",1,"Xanomeline High Dose",2,"Headache","Headache","Nervous system disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-03-08,2013-04-21,33,77,45,"DAY","Y","Y","Y",NA,NA,NA,72,"65-80","F",20,"Y"
"CDISCPILOT01","01-703-003",1,"Xanomeline High Dose",2,"Application site irritation","Application site irritation","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-08-27,2013-09-20,15,39,25,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,78,"65-80","F",24,"Y"
"CDISCPILOT01","01-703-003",2,"Xanomeline High Dose",2,"Syncope","Syncope","Nervous system disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-10-25,2013-11-20,74,100,27,"DAY","Y","Y","Y",NA,NA,NA,78,"65-80","F",24,"Y"
"CDISCPILOT01","01-703-004",1,"Placebo",0,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-08-08,2013-08-10,9,11,3,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,75,"65-80","F",15,"Y"
"CDISCPILOT01","01-703-004",3,"Placebo",0,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-08-14,2013-08-25,15,26,12,"DAY","Y","Y","Y",NA,NA,NA,75,"65-80","F",15,"Y"
"CDISCPILOT01","01-703-004",2,"Placebo",0,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-09-29,2013-11-01,61,94,34,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",75,"65-80","F",15,"Y"
"CDISCPILOT01","01-703-004",4,"Placebo",0,"Nasopharyngitis","Nasopharyngitis","Infections and infestations","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-10-24,2013-12-05,86,128,43,"DAY","Y","Y","Y",NA,NA,NA,75,"65-80","F",15,"Y"
"CDISCPILOT01","01-703-008",1,"Xanomeline Low Dose",1,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2014-02-13,2014-03-09,43,67,25,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",54,"<65","F",13,"Y"
"CDISCPILOT01","01-703-011",1,"Xanomeline High Dose",2,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2014-01-07,2014-01-15,16,24,9,"DAY","Y","Y","Y",NA,NA,NA,89,">80","M",15,"Y"
"CDISCPILOT01","01-703-011",2,"Xanomeline High Dose",2,"Nasopharyngitis","Nasopharyngitis","Infections and infestations","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-12-28,2014-01-20,6,29,24,"DAY","Y","Y","Y",NA,NA,NA,89,">80","M",15,"Y"
"CDISCPILOT01","01-703-013",1,"Xanomeline Low Dose",1,"Rash","Rash","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-05-20,2013-05-26,22,28,7,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",78,"65-80","M",14,"Y"
"CDISCPILOT01","01-703-015",4,"Xanomeline Low Dose",1,"Agitation","Agitation","Psychiatric disorders","GENERAL","SEVERE",3,3,"Y","NOT RELATED","N",0,2013-03-30,2013-04-23,47,71,25,"DAY","Y","Y","Y","Y",NA,NA,87,">80","F",21,"Y"
"CDISCPILOT01","01-703-015",1,"Xanomeline Low Dose",1,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-02-23,2013-03-13,12,30,19,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,87,">80","F",21,"Y"
"CDISCPILOT01","01-703-015",5,"Xanomeline Low Dose",1,"Cough","Cough","Respiratory, thoracic and mediastinal disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-06-12,2013-06-28,121,137,17,"DAY","Y","Y","Y",NA,NA,NA,87,">80","F",21,"Y"
"CDISCPILOT01","01-703-015",3,"Xanomeline Low Dose",1,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-05-13,2013-05-13,91,91,1,"DAY","Y","Y","Y",NA,NA,NA,87,">80","F",21,"Y"
"CDISCPILOT01","01-703-015",2,"Xanomeline Low Dose",1,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"Y","POSSIBLY RELATED","Y",1,2013-05-10,2013-05-12,88,90,3,"DAY","Y","Y","Y","Y",NA,"DERMATOLOGICAL AE",87,">80","F",21,"Y"
"CDISCPILOT01","01-703-017",2,"Xanomeline Low Dose",1,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-12-16,2014-01-25,28,68,41,"DAY","Y","Y","Y",NA,NA,NA,61,"<65","F",18,"Y"
"CDISCPILOT01","01-703-017",1,"Xanomeline Low Dose",1,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-11-23,2014-01-04,5,47,43,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",61,"<65","F",18,"Y"
"CDISCPILOT01","01-703-019",1,"Xanomeline High Dose",2,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-11-27,2013-12-15,24,42,19,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",62,"<65","F",17,"Y"
"CDISCPILOT01","01-703-019",2,"Xanomeline High Dose",2,"Skin irritation","Skin irritation","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-11-07,2013-11-10,4,7,4,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",62,"<65","F",17,"Y"
"CDISCPILOT01","01-703-020",1,"Xanomeline Low Dose",1,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-07-08,2013-07-31,1,24,24,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",72,"65-80","F",24,"Y"
"CDISCPILOT01","01-704-002",1,"Placebo",0,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-03-13,2013-05-01,20,69,50,"DAY","Y","Y","Y",NA,NA,NA,89,">80","M",18,"Y"
"CDISCPILOT01","01-704-003",1,"Xanomeline Low Dose",1,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-07-01,2013-07-13,9,21,13,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,78,"65-80","M",14,"Y"
"CDISCPILOT01","01-704-003",2,"Xanomeline Low Dose",1,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-08-06,2013-08-25,45,64,20,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",78,"65-80","M",14,"Y"
"CDISCPILOT01","01-704-007",1,"Placebo",0,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2014-01-11,2014-02-08,26,54,29,"DAY","Y","Y","Y",NA,NA,NA,73,"65-80","F",19,"Y"
"CDISCPILOT01","01-704-008",1,"Xanomeline High Dose",2,"Application site irritation","Application site irritation","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-07-20,2013-07-31,15,26,12,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,78,"65-80","F",24,"Y"
"CDISCPILOT01","01-704-008",2,"Xanomeline High Dose",2,"Hyperhidrosis","Hyperhidrosis","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-10-13,2013-10-28,100,115,16,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",78,"65-80","F",24,"Y"
"CDISCPILOT01","01-704-009",1,"Xanomeline High Dose",2,"Rash","Rash","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-07-25,2013-07-28,14,17,4,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",75,"65-80","M",11,"Y"
"CDISCPILOT01","01-704-010",1,"Xanomeline High Dose",2,"Application site dermatitis","Application site dermatitis","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-09-25,2013-10-19,4,28,25,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,72,"65-80","F",18,"Y"
"CDISCPILOT01","01-704-010",4,"Xanomeline High Dose",2,"Myocardial infarction","Myocardial infarction","Cardiac disorders","GENERAL","SEVERE",3,3,"Y","NOT RELATED","N",0,2013-10-30,2013-11-29,39,69,31,"DAY","Y","Y","Y","Y",NA,NA,72,"65-80","F",18,"Y"
"CDISCPILOT01","01-704-010",3,"Xanomeline High Dose",2,"Nausea","Nausea","Gastrointestinal disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-10-23,2013-11-14,32,54,23,"DAY","Y","Y","Y",NA,NA,NA,72,"65-80","F",18,"Y"
"CDISCPILOT01","01-704-010",2,"Xanomeline High Dose",2,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-10-10,2013-10-29,19,38,20,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",72,"65-80","F",18,"Y"
"CDISCPILOT01","01-704-013",1,"Placebo",0,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-05-23,2013-05-29,17,23,7,"DAY","Y","Y","Y",NA,NA,NA,66,"65-80","F",20,"Y"
"CDISCPILOT01","01-704-016",2,"Xanomeline Low Dose",1,"Fatigue","Fatigue","General disorders and administration site conditions","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-09-19,2013-10-04,17,32,16,"DAY","Y","Y","Y",NA,NA,NA,89,">80","M",21,"Y"
"CDISCPILOT01","01-704-016",1,"Xanomeline Low Dose",1,"Nasal congestion","Nasal congestion","Respiratory, thoracic and mediastinal disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-09-10,2013-10-05,8,33,26,"DAY","Y","Y","Y",NA,NA,NA,89,">80","M",21,"Y"
"CDISCPILOT01","01-704-017",1,"Placebo",0,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-01-16,2013-02-15,5,35,31,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,62,"<65","F",21,"Y"
"CDISCPILOT01","01-704-017",2,"Placebo",0,"Hyperhidrosis","Hyperhidrosis","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-03-10,2013-04-05,58,84,27,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",62,"<65","F",21,"Y"
"CDISCPILOT01","01-704-017",3,"Placebo",0,"Nausea","Nausea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-06-08,2013-06-24,148,164,17,"DAY","Y","Y","Y",NA,NA,NA,62,"<65","F",21,"Y"
"CDISCPILOT01","01-704-018",1,"Placebo",0,"Application site irritation","Application site irritation","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-06-30,2013-07-14,9,23,15,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,61,"<65","F",19,"Y"
"CDISCPILOT01","01-704-019",1,"Xanomeline Low Dose",1,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-08-17,2013-08-21,10,14,5,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,75,"65-80","F",24,"Y"
"CDISCPILOT01","01-704-019",2,"Xanomeline Low Dose",1,"Application site vesicles","Application site vesicles","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-08-10,2013-08-22,3,15,13,"DAY","Y","Y",NA,NA,"APPLICATION SITE REACTION",NA,75,"65-80","F",24,"Y"
"CDISCPILOT01","01-704-019",5,"Xanomeline Low Dose",1,"Fatigue","Fatigue","General disorders and administration site conditions","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-09-15,2013-09-22,39,46,8,"DAY","Y","Y",NA,NA,NA,NA,75,"65-80","F",24,"Y"
"CDISCPILOT01","01-704-019",4,"Xanomeline Low Dose",1,"Headache","Headache","Nervous system disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-08-27,2013-09-02,20,26,7,"DAY","Y","Y","Y",NA,NA,NA,75,"65-80","F",24,"Y"
"CDISCPILOT01","01-704-019",3,"Xanomeline Low Dose",1,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-09-23,2013-10-07,47,61,15,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",75,"65-80","F",24,"Y"
"CDISCPILOT01","01-704-021",1,"Placebo",0,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-07-08,2013-07-27,39,58,20,"DAY","Y","Y","Y",NA,NA,NA,84,">80","M",11,"Y"
"CDISCPILOT01","01-704-022",1,"Xanomeline Low Dose",1,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-03-01,2013-03-24,31,54,24,"DAY","Y","Y","Y",NA,NA,NA,74,"65-80","M",17,"Y"
"CDISCPILOT01","01-704-023",1,"Xanomeline High Dose",2,"Sinus bradycardia","Sinus bradycardia","Cardiac disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-09-18,2013-09-30,12,24,13,"DAY","Y","Y","Y",NA,NA,NA,68,"65-80","M",15,"Y"
"CDISCPILOT01","01-705-001",1,"Xanomeline High Dose",2,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-09-23,2013-11-05,52,95,44,"DAY","Y","Y","Y",NA,NA,NA,62,"<65","M",15,"Y"
"CDISCPILOT01","01-705-002",1,"Xanomeline High Dose",2,"Vomiting","Vomiting","Gastrointestinal disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-09-26,2013-09-30,42,46,5,"DAY","Y","Y","Y",NA,NA,NA,68,"65-80","M",23,"Y"
"CDISCPILOT01","01-705-004",1,"Xanomeline High Dose",2,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-09-19,2013-09-28,11,20,10,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,76,"65-80","F",23,"Y"
"CDISCPILOT01","01-705-008",1,"Placebo",0,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-06-05,2013-06-07,20,22,3,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,82,">80","F",18,"Y"
"CDISCPILOT01","01-705-009",1,"Placebo",0,"Application site irritation","Application site irritation","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-09-09,2013-10-05,2,28,27,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,84,">80","F",21,"Y"
"CDISCPILOT01","01-705-010",1,"Placebo",0,"Application site dermatitis","Application site dermatitis","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-08-17,2013-08-18,15,16,2,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,86,">80","F",21,"Y"
"CDISCPILOT01","01-705-010",2,"Placebo",0,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-08-29,2013-09-30,27,59,33,"DAY","Y","Y","Y",NA,NA,NA,86,">80","F",21,"Y"
"CDISCPILOT01","01-705-013",1,"Placebo",0,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-02-21,2013-03-12,14,33,20,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,85,">80","F",12,"Y"
"CDISCPILOT01","01-705-013",2,"Placebo",0,"Insomnia","Insomnia","Psychiatric disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-03-17,2013-03-28,38,49,12,"DAY","Y","Y","Y",NA,NA,NA,85,">80","F",12,"Y"
"CDISCPILOT01","01-705-014",1,"Xanomeline High Dose",2,"Nasopharyngitis","Nasopharyngitis","Infections and infestations","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-04-10,2013-04-17,46,53,8,"DAY","Y","Y","Y",NA,NA,NA,77,"65-80","F",18,"Y"
"CDISCPILOT01","01-706-001",1,"Xanomeline High Dose",2,"Nasal congestion","Nasal congestion","Respiratory, thoracic and mediastinal disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-03-13,2013-04-14,41,73,33,"DAY","Y","Y","Y",NA,NA,NA,80,">80","M",23,"Y"
"CDISCPILOT01","01-706-002",2,"Placebo",0,"Hyperhidrosis","Hyperhidrosis","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-02-25,2013-03-10,10,23,14,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",63,"<65","F",18,"Y"
"CDISCPILOT01","01-706-002",1,"Placebo",0,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-04-08,2013-05-03,52,77,26,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",63,"<65","F",18,"Y"
"CDISCPILOT01","01-706-003",1,"Xanomeline Low Dose",1,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-04-10,2013-05-01,31,52,22,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",69,"65-80","M",23,"Y"
"CDISCPILOT01","01-707-002",1,"Placebo",0,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-12-03,2013-12-21,103,121,19,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",83,">80","M",24,"Y"
"CDISCPILOT01","01-707-002",2,"Placebo",0,"Nasopharyngitis","Nasopharyngitis","Infections and infestations","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-10-15,2013-11-06,54,76,23,"DAY","Y","Y","Y",NA,NA,NA,83,">80","M",24,"Y"
"CDISCPILOT01","01-708-001",1,"Placebo",0,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-12-01,2013-12-18,21,38,18,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,87,">80","F",19,"Y"
"CDISCPILOT01","01-708-001",3,"Placebo",0,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2014-01-04,2014-02-09,55,91,37,"DAY","Y","Y","Y",NA,NA,NA,87,">80","F",19,"Y"
"CDISCPILOT01","01-708-001",2,"Placebo",0,"Somnolence","Somnolence","Nervous system disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-11-21,2013-12-05,11,25,15,"DAY","Y","Y","Y",NA,NA,NA,87,">80","F",19,"Y"
"CDISCPILOT01","01-708-002",1,"Xanomeline Low Dose",1,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-09-03,2013-09-25,7,29,23,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,83,">80","M",24,"Y"
"CDISCPILOT01","01-708-003",1,"Xanomeline High Dose",2,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-11-05,2013-11-20,8,23,16,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",67,"65-80","M",15,"Y"
"CDISCPILOT01","01-708-006",1,"Xanomeline Low Dose",1,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-10-31,2013-11-07,25,32,8,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,70,"65-80","F",23,"Y"
"CDISCPILOT01","01-708-006",4,"Xanomeline Low Dose",1,"Fatigue","Fatigue","General disorders and administration site conditions","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-11-03,2013-11-26,28,51,24,"DAY","Y","Y",NA,NA,NA,NA,70,"65-80","F",23,"Y"
"CDISCPILOT01","01-708-006",2,"Xanomeline Low Dose",1,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-11-20,2013-12-06,45,61,17,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",70,"65-80","F",23,"Y"
"CDISCPILOT01","01-708-006",3,"Xanomeline Low Dose",1,"Rash","Rash","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-12-21,2014-02-04,76,121,46,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",70,"65-80","F",23,"Y"
"CDISCPILOT01","01-708-007",3,"Xanomeline High Dose",2,"Application site dermatitis","Application site dermatitis","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-05-30,2013-06-08,11,20,10,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,83,">80","F",21,"Y"
"CDISCPILOT01","01-708-007",2,"Xanomeline High Dose",2,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-05-25,2013-06-17,6,29,24,"DAY","Y","Y",NA,NA,"APPLICATION SITE REACTION",NA,83,">80","F",21,"Y"
"CDISCPILOT01","01-708-007",1,"Xanomeline High Dose",2,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-06-04,2013-06-20,16,32,17,"DAY","Y","Y",NA,NA,"APPLICATION SITE REACTION",NA,83,">80","F",21,"Y"
"CDISCPILOT01","01-708-010",1,"Xanomeline Low Dose",1,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-08-01,2013-08-08,27,34,8,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,68,"65-80","F",18,"Y"
"CDISCPILOT01","01-708-011",1,"Xanomeline Low Dose",1,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-12-25,2014-01-13,22,41,20,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,63,"<65","F",19,"Y"
"CDISCPILOT01","01-708-012",1,"Placebo",0,"Application site vesicles","Application site vesicles","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-06-26,2013-07-07,18,29,12,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,89,">80","F",12,"Y"
"CDISCPILOT01","01-708-012",2,"Placebo",0,"Confusional state","Confusional state","Psychiatric disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-06-20,2013-08-25,12,78,67,"DAY","Y","Y","Y",NA,NA,NA,89,">80","F",12,"Y"
"CDISCPILOT01","01-708-013",2,"Xanomeline High Dose",2,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-04-19,2013-05-16,16,43,28,"DAY","Y","Y","Y",NA,NA,NA,81,">80","M",22,"Y"
"CDISCPILOT01","01-708-013",1,"Xanomeline High Dose",2,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"Y","POSSIBLY RELATED","Y",1,2013-05-15,2013-05-29,42,56,15,"DAY","Y","Y","Y","Y",NA,"DERMATOLOGICAL AE",81,">80","M",22,"Y"
"CDISCPILOT01","01-708-015",1,"Placebo",0,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-12-10,2013-12-19,66,75,10,"DAY","Y","Y","Y",NA,NA,NA,80,">80","M",15,"Y"
"CDISCPILOT01","01-708-015",2,"Placebo",0,"Myocardial infarction","Myocardial infarction","Cardiac disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-12-26,2014-01-01,82,88,7,"DAY","Y","Y","Y",NA,NA,NA,80,">80","M",15,"Y"
"CDISCPILOT01","01-708-017",1,"Xanomeline High Dose",2,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-10-19,2013-10-30,9,20,12,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,65,"65-80","F",19,"Y"
"CDISCPILOT01","01-708-017",2,"Xanomeline High Dose",2,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","SEVERE",3,3,"Y","POSSIBLY RELATED","Y",1,2013-11-24,2013-12-22,45,73,29,"DAY","Y","Y","Y","Y",NA,"DERMATOLOGICAL AE",65,"65-80","F",19,"Y"
"CDISCPILOT01","01-708-017",3,"Xanomeline High Dose",2,"Rash","Rash","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-10-27,2013-11-07,17,28,12,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",65,"65-80","F",19,"Y"
"CDISCPILOT01","01-708-020",1,"Placebo",0,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-10-16,2013-10-25,82,91,10,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",73,"65-80","F",11,"Y"
"CDISCPILOT01","01-708-020",2,"Placebo",0,"Skin irritation","Skin irritation","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-11-03,2013-11-06,100,103,4,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",73,"65-80","F",11,"Y"
"CDISCPILOT01","01-709-002",1,"Placebo",0,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-03-08,2013-03-22,14,28,15,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,84,">80","M",15,"Y"
"CDISCPILOT01","01-709-002",2,"Placebo",0,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-03-04,2013-03-23,10,29,20,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",84,">80","M",15,"Y"
"CDISCPILOT01","01-709-002",3,"Placebo",0,"Nausea","Nausea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-05-25,2013-07-04,92,132,41,"DAY","Y","Y","Y",NA,NA,NA,84,">80","M",15,"Y"
"CDISCPILOT01","01-709-003",1,"Xanomeline High Dose",2,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-11-03,2013-11-07,14,18,5,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,69,"65-80","F",24,"Y"
"CDISCPILOT01","01-709-003",3,"Xanomeline High Dose",2,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-10-29,2013-12-05,9,46,38,"DAY","Y","Y","Y",NA,NA,NA,69,"65-80","F",24,"Y"
"CDISCPILOT01","01-709-003",4,"Xanomeline High Dose",2,"Nasal congestion","Nasal congestion","Respiratory, thoracic and mediastinal disorders","GENERAL","MODERATE",2,2,"Y","POSSIBLY RELATED","Y",1,2013-12-20,2014-01-10,61,82,22,"DAY","Y","Y","Y","Y",NA,NA,69,"65-80","F",24,"Y"
"CDISCPILOT01","01-709-003",2,"Xanomeline High Dose",2,"Rash","Rash","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-11-25,2013-12-05,36,46,11,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",69,"65-80","F",24,"Y"
"CDISCPILOT01","01-709-004",1,"Xanomeline High Dose",2,"Application site irritation","Application site irritation","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-10-25,2013-11-05,11,22,12,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,75,"65-80","F",11,"Y"
"CDISCPILOT01","01-709-004",3,"Xanomeline High Dose",2,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-11-07,2013-11-22,24,39,16,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",75,"65-80","F",11,"Y"
"CDISCPILOT01","01-709-004",4,"Xanomeline High Dose",2,"Fatigue","Fatigue","General disorders and administration site conditions","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-12-03,2013-12-20,50,67,18,"DAY","Y","Y",NA,NA,NA,NA,75,"65-80","F",11,"Y"
"CDISCPILOT01","01-709-004",2,"Xanomeline High Dose",2,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-10-23,2013-12-07,9,54,46,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",75,"65-80","F",11,"Y"
"CDISCPILOT01","01-709-005",1,"Xanomeline High Dose",2,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-04-17,2013-05-09,35,57,23,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",89,">80","F",17,"Y"
"CDISCPILOT01","01-709-005",2,"Xanomeline High Dose",2,"Rash","Rash","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-03-22,2013-04-11,9,29,21,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",89,">80","F",17,"Y"
"CDISCPILOT01","01-709-006",1,"Xanomeline Low Dose",1,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-04-27,2013-05-07,18,28,11,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,60,"<65","M",24,"Y"
"CDISCPILOT01","01-709-006",2,"Xanomeline Low Dose",1,"Application site irritation","Application site irritation","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-04-14,2013-04-21,5,12,8,"DAY","Y","Y",NA,NA,"APPLICATION SITE REACTION",NA,60,"<65","M",24,"Y"
"CDISCPILOT01","01-709-008",1,"Placebo",0,"Myocardial infarction","Myocardial infarction","Cardiac disorders","GENERAL","SEVERE",3,3,"Y","RELATED","Y",1,2013-08-02,2013-09-01,60,90,31,"DAY","Y","Y","Y","Y",NA,NA,59,"<65","F",19,"Y"
"CDISCPILOT01","01-709-013",1,"Xanomeline High Dose",2,"Vomiting","Vomiting","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-06-11,2013-06-23,66,78,13,"DAY","Y","Y","Y",NA,NA,NA,73,"65-80","F",12,"Y"
"CDISCPILOT01","01-709-015",1,"Xanomeline Low Dose",1,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-07-13,2013-07-28,70,85,16,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",78,"65-80","F",19,"Y"
"CDISCPILOT01","01-709-015",2,"Xanomeline Low Dose",1,"Rash","Rash","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-05-30,2013-06-11,26,38,13,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",78,"65-80","F",19,"Y"
"CDISCPILOT01","01-709-015",3,"Xanomeline Low Dose",1,"Sinus bradycardia","Sinus bradycardia","Cardiac disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-06-16,2013-07-09,43,66,24,"DAY","Y","Y","Y",NA,NA,NA,78,"65-80","F",19,"Y"
"CDISCPILOT01","01-709-016",1,"Xanomeline High Dose",2,"Skin irritation","Skin irritation","Skin and subcutaneous tissue disorders","GENERAL","SEVERE",3,3,"Y","NOT RELATED","N",0,2013-04-26,2013-05-09,22,35,14,"DAY","Y","Y","Y","Y",NA,"DERMATOLOGICAL AE",83,">80","F",10,"Y"
"CDISCPILOT01","01-709-017",1,"Xanomeline High Dose",2,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-03-08,2013-03-17,65,74,10,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",79,"65-80","M",18,"Y"
"CDISCPILOT01","01-709-018",1,"Placebo",0,"Sinus bradycardia","Sinus bradycardia","Cardiac disorders","GENERAL","SEVERE",3,3,"Y","NOT RELATED","N",0,2013-03-01,2013-04-03,30,63,34,"DAY","Y","Y","Y","Y",NA,NA,74,"65-80","F",18,"Y"
"CDISCPILOT01","01-709-021",1,"Placebo",0,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-04-10,2013-05-08,2,30,29,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",81,">80","M",17,"Y"
"CDISCPILOT01","01-709-023",2,"Xanomeline Low Dose",1,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-09-01,2013-09-29,62,90,29,"DAY","Y","Y","Y",NA,NA,NA,74,"65-80","F",22,"Y"
"CDISCPILOT01","01-709-023",1,"Xanomeline Low Dose",1,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-08-26,2013-08-30,56,60,5,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",74,"65-80","F",22,"Y"
"CDISCPILOT01","01-710-001",1,"Xanomeline High Dose",2,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-04-16,2013-05-04,17,35,19,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,76,"65-80","M",11,"Y"
"CDISCPILOT01","01-710-001",2,"Xanomeline High Dose",2,"Application site vesicles","Application site vesicles","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-04-04,2013-04-12,5,13,9,"DAY","Y","Y",NA,NA,"APPLICATION SITE REACTION",NA,76,"65-80","M",11,"Y"
"CDISCPILOT01","01-710-001",3,"Xanomeline High Dose",2,"Cough","Cough","Respiratory, thoracic and mediastinal disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-04-28,2013-05-13,29,44,16,"DAY","Y","Y","Y",NA,NA,NA,76,"65-80","M",11,"Y"
"CDISCPILOT01","01-710-001",4,"Xanomeline High Dose",2,"Fatigue","Fatigue","General disorders and administration site conditions","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-06-14,2013-06-15,76,77,2,"DAY","Y","Y",NA,NA,NA,NA,76,"65-80","M",11,"Y"
"CDISCPILOT01","01-710-003",2,"Xanomeline Low Dose",1,"Agitation","Agitation","Psychiatric disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2014-02-03,2014-03-12,71,108,38,"DAY","Y","Y","Y",NA,NA,NA,77,"65-80","M",13,"Y"
"CDISCPILOT01","01-710-003",1,"Xanomeline Low Dose",1,"Skin irritation","Skin irritation","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2014-02-11,2014-02-24,79,92,14,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",77,"65-80","M",13,"Y"
"CDISCPILOT01","01-710-004",1,"Placebo",0,"Application site dermatitis","Application site dermatitis","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-04-22,2013-05-18,4,30,27,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,74,"65-80","M",16,"Y"
"CDISCPILOT01","01-710-004",2,"Placebo",0,"Insomnia","Insomnia","Psychiatric disorders","GENERAL","LIFE-THREATENING",4,4,"Y","RELATED","Y",1,2013-05-06,2013-05-11,18,23,6,"DAY","Y","Y","Y","Y",NA,NA,74,"65-80","M",16,"Y"
"CDISCPILOT01","01-710-005",1,"Xanomeline High Dose",2,"Myocardial infarction","Myocardial infarction","Cardiac disorders","GENERAL","LIFE-THREATENING",4,4,"Y","POSSIBLY RELATED","Y",1,2013-02-07,2013-02-14,16,23,8,"DAY","Y","Y","Y","Y",NA,NA,77,"65-80","F",18,"Y"
"CDISCPILOT01","01-710-006",1,"Placebo",0,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-06-21,2013-07-30,54,93,40,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",78,"65-80","M",21,"Y"
"CDISCPILOT01","01-710-007",1,"Xanomeline High Dose",2,"Confusional state","Confusional state","Psychiatric disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-05-16,2013-05-27,10,21,12,"DAY","Y","Y","Y",NA,NA,NA,64,"<65","F",18,"Y"
"CDISCPILOT01","01-710-008",1,"Xanomeline Low Dose",1,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-11-10,2013-11-20,14,24,11,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",66,"65-80","M",20,"Y"
"CDISCPILOT01","01-710-008",2,"Xanomeline Low Dose",1,"Sinus bradycardia","Sinus bradycardia","Cardiac disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-11-09,2013-11-27,13,31,19,"DAY","Y","Y","Y",NA,NA,NA,66,"65-80","M",20,"Y"
"CDISCPILOT01","01-710-010",2,"Xanomeline Low Dose",1,"Application site irritation","Application site irritation","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-07-30,2013-08-20,15,36,22,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,65,"65-80","F",16,"Y"
"CDISCPILOT01","01-710-010",1,"Xanomeline Low Dose",1,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-08-01,2013-08-16,17,32,16,"DAY","Y","Y",NA,NA,"APPLICATION SITE REACTION",NA,65,"65-80","F",16,"Y"
"CDISCPILOT01","01-710-013",1,"Placebo",0,"Cough","Cough","Respiratory, thoracic and mediastinal disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2014-01-03,2014-01-16,49,62,14,"DAY","Y","Y","Y",NA,NA,NA,59,"<65","M",10,"Y"
"CDISCPILOT01","01-710-014",1,"Placebo",0,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-06-21,2013-06-28,7,14,8,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,78,"65-80","F",19,"Y"
"CDISCPILOT01","01-710-014",3,"Placebo",0,"Myocardial infarction","Myocardial infarction","Cardiac disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-09-11,2013-09-22,89,100,12,"DAY","Y","Y","Y",NA,NA,NA,78,"65-80","F",19,"Y"
"CDISCPILOT01","01-710-014",2,"Placebo",0,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-08-17,2013-08-21,64,68,5,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",78,"65-80","F",19,"Y"
"CDISCPILOT01","01-710-015",1,"Placebo",0,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-07-30,2013-08-02,3,6,4,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",61,"<65","F",17,"Y"
"CDISCPILOT01","01-710-018",1,"Placebo",0,"Nasopharyngitis","Nasopharyngitis","Infections and infestations","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-11-08,2013-11-30,72,94,23,"DAY","Y","Y","Y",NA,NA,NA,78,"65-80","M",24,"Y"
"CDISCPILOT01","01-710-020",2,"Placebo",0,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","SEVERE",3,3,"Y","RELATED","Y",1,2013-06-12,2013-06-26,21,35,15,"DAY","Y","Y","Y","Y",NA,NA,85,">80","F",24,"Y"
"CDISCPILOT01","01-710-020",1,"Placebo",0,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-06-04,2013-06-15,13,24,12,"DAY","Y","Y","Y",NA,NA,NA,85,">80","F",24,"Y"
"CDISCPILOT01","01-710-022",1,"Xanomeline Low Dose",1,"Application site dermatitis","Application site dermatitis","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-03-14,2013-03-20,9,15,7,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,82,">80","M",23,"Y"
"CDISCPILOT01","01-710-022",4,"Xanomeline Low Dose",1,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-05-31,2013-07-13,87,130,44,"DAY","Y","Y","Y",NA,NA,NA,82,">80","M",23,"Y"
"CDISCPILOT01","01-710-022",2,"Xanomeline Low Dose",1,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-07-17,2013-07-23,134,140,7,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",82,">80","M",23,"Y"
"CDISCPILOT01","01-710-022",3,"Xanomeline Low Dose",1,"Somnolence","Somnolence","Nervous system disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-03-14,2013-03-31,9,26,18,"DAY","Y","Y","Y",NA,NA,NA,82,">80","M",23,"Y"
"CDISCPILOT01","01-710-023",2,"Placebo",0,"Agitation","Agitation","Psychiatric disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-06-28,2013-07-12,48,62,15,"DAY","Y","Y","Y",NA,NA,NA,89,">80","F",22,"Y"
"CDISCPILOT01","01-710-023",1,"Placebo",0,"Application site dermatitis","Application site dermatitis","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-05-23,2013-05-27,12,16,5,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,89,">80","F",22,"Y"
"CDISCPILOT01","01-710-024",1,"Xanomeline Low Dose",1,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-10-04,2013-11-15,16,58,43,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,80,">80","F",21,"Y"
"CDISCPILOT01","01-710-024",2,"Xanomeline Low Dose",1,"Rash","Rash","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-10-03,2013-11-06,15,49,35,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",80,">80","F",21,"Y"
"CDISCPILOT01","01-710-025",1,"Xanomeline Low Dose",1,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-10-26,2013-11-27,34,66,33,"DAY","Y","Y","Y",NA,NA,NA,71,"65-80","M",19,"Y"
"CDISCPILOT01","01-710-026",1,"Xanomeline High Dose",2,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-03-03,2013-03-09,16,22,7,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,77,"65-80","F",21,"Y"
"CDISCPILOT01","01-710-027",1,"Xanomeline Low Dose",1,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-03-17,2013-04-02,8,24,17,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,85,">80","M",11,"Y"
"CDISCPILOT01","01-710-028",1,"Xanomeline High Dose",2,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-08-27,2013-09-02,5,11,7,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,69,"65-80","M",24,"Y"
"CDISCPILOT01","01-710-028",4,"Xanomeline High Dose",2,"Fatigue","Fatigue","General disorders and administration site conditions","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-09-07,2013-09-21,16,30,15,"DAY","Y","Y",NA,NA,NA,NA,69,"65-80","M",24,"Y"
"CDISCPILOT01","01-710-028",2,"Xanomeline High Dose",2,"Hyperhidrosis","Hyperhidrosis","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-09-08,2013-09-12,17,21,5,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",69,"65-80","M",24,"Y"
"CDISCPILOT01","01-710-028",3,"Xanomeline High Dose",2,"Skin irritation","Skin irritation","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-09-09,2013-10-03,18,42,25,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",69,"65-80","M",24,"Y"
"CDISCPILOT01","01-710-029",1,"Placebo",0,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-11-08,2013-12-02,35,59,25,"DAY","Y","Y","Y",NA,NA,NA,75,"65-80","F",18,"Y"
"CDISCPILOT01","01-711-001",1,"Placebo",0,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-08-14,2013-09-12,8,37,30,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",78,"65-80","F",15,"Y"
"CDISCPILOT01","01-711-002",2,"Placebo",0,"Application site irritation","Application site irritation","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-01-09,2013-01-11,6,8,3,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,71,"65-80","F",15,"Y"
"CDISCPILOT01","01-711-002",1,"Placebo",0,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-01-04,2013-01-06,1,3,3,"DAY","Y","Y",NA,NA,"APPLICATION SITE REACTION",NA,71,"65-80","F",15,"Y"
"CDISCPILOT01","01-711-002",3,"Placebo",0,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-01-22,2013-02-26,19,54,36,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",71,"65-80","F",15,"Y"
"CDISCPILOT01","01-713-001",1,"Placebo",0,"Headache","Headache","Nervous system disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-01-27,2013-02-15,24,43,20,"DAY","Y","Y","Y",NA,NA,NA,75,"65-80","M",15,"Y"
"CDISCPILOT01","01-713-002",2,"Xanomeline Low Dose",1,"Application site dermatitis","Application site dermatitis","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-06-08,2013-06-23,12,27,16,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,64,"<65","M",17,"Y"
"CDISCPILOT01","01-713-002",1,"Xanomeline Low Dose",1,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-06-07,2013-07-25,11,59,49,"DAY","Y","Y",NA,NA,"APPLICATION SITE REACTION",NA,64,"<65","M",17,"Y"
"CDISCPILOT01","01-713-002",3,"Xanomeline Low Dose",1,"Fatigue","Fatigue","General disorders and administration site conditions","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-06-16,2013-07-13,20,47,28,"DAY","Y","Y",NA,NA,NA,NA,64,"<65","M",17,"Y"
"CDISCPILOT01","01-713-004",1,"Xanomeline High Dose",2,"Application site vesicles","Application site vesicles","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-06-24,2013-07-05,3,14,12,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,81,">80","F",14,"Y"
"CDISCPILOT01","01-713-004",3,"Xanomeline High Dose",2,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-07-22,2013-08-05,31,45,15,"DAY","Y","Y","Y",NA,NA,NA,81,">80","F",14,"Y"
"CDISCPILOT01","01-713-004",4,"Xanomeline High Dose",2,"Myocardial infarction","Myocardial infarction","Cardiac disorders","GENERAL","LIFE-THREATENING",4,4,"Y","RELATED","Y",1,2013-07-11,2013-07-15,20,24,5,"DAY","Y","Y","Y","Y",NA,NA,81,">80","F",14,"Y"
"CDISCPILOT01","01-713-004",2,"Xanomeline High Dose",2,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-07-21,2013-07-23,30,32,3,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",81,">80","F",14,"Y"
"CDISCPILOT01","01-714-003",1,"Xanomeline Low Dose",1,"Application site vesicles","Application site vesicles","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-10-28,2013-11-04,4,11,8,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,69,"65-80","F",16,"Y"
"CDISCPILOT01","01-714-003",2,"Xanomeline Low Dose",1,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-12-07,2013-12-28,44,65,22,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",69,"65-80","F",16,"Y"
"CDISCPILOT01","01-714-003",3,"Xanomeline Low Dose",1,"Sinus bradycardia","Sinus bradycardia","Cardiac disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-11-16,2013-12-24,23,61,39,"DAY","Y","Y","Y",NA,NA,NA,69,"65-80","F",16,"Y"
"CDISCPILOT01","01-715-001",2,"Xanomeline High Dose",2,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-08-18,2013-08-24,17,23,7,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",70,"65-80","F",24,"Y"
"CDISCPILOT01","01-715-001",1,"Xanomeline High Dose",2,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-09-15,2013-09-18,45,48,4,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",70,"65-80","F",24,"Y"
"CDISCPILOT01","01-715-004",1,"Placebo",0,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-11-28,2013-12-10,38,50,13,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",76,"65-80","F",22,"Y"
"CDISCPILOT01","01-715-005",1,"Placebo",0,"Application site dermatitis","Application site dermatitis","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-12-25,2014-01-14,17,37,21,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,66,"65-80","F",15,"Y"
"CDISCPILOT01","01-715-007",1,"Placebo",0,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-12-14,2013-12-20,37,43,7,"DAY","Y","Y","Y",NA,NA,NA,62,"<65","F",16,"Y"
"CDISCPILOT01","01-716-001",1,"Xanomeline Low Dose",1,"Rash","Rash","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-06-09,2013-06-19,21,31,11,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",76,"65-80","M",20,"Y"
"CDISCPILOT01","01-716-003",1,"Placebo",0,"Upper respiratory tract infection","Upper respiratory tract infection","Infections and infestations","GENERAL","SEVERE",3,3,"Y","NOT RELATED","N",0,2013-11-27,2013-12-11,14,28,15,"DAY","Y","Y","Y","Y",NA,NA,76,"65-80","F",22,"Y"
"CDISCPILOT01","01-716-004",2,"Xanomeline High Dose",2,"Agitation","Agitation","Psychiatric disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-11-06,2013-11-16,59,69,11,"DAY","Y","Y","Y",NA,NA,NA,70,"65-80","F",18,"Y"
"CDISCPILOT01","01-716-004",1,"Xanomeline High Dose",2,"Nausea","Nausea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-10-08,2013-10-20,30,42,13,"DAY","Y","Y","Y",NA,NA,NA,70,"65-80","F",18,"Y"
"CDISCPILOT01","01-716-008",1,"Xanomeline High Dose",2,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-06-09,2013-06-11,48,50,3,"DAY","Y","Y","Y",NA,NA,NA,78,"65-80","F",13,"Y"
"CDISCPILOT01","01-716-009",2,"Xanomeline High Dose",2,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-10-21,2013-11-04,28,42,15,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,78,"65-80","M",19,"Y"
"CDISCPILOT01","01-716-009",1,"Xanomeline High Dose",2,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-10-03,2013-10-31,10,38,29,"DAY","Y","Y",NA,NA,"APPLICATION SITE REACTION",NA,78,"65-80","M",19,"Y"
"CDISCPILOT01","01-716-009",3,"Xanomeline High Dose",2,"Hyperhidrosis","Hyperhidrosis","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-11-25,2013-12-13,63,81,19,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",78,"65-80","M",19,"Y"
"CDISCPILOT01","01-716-010",1,"Xanomeline High Dose",2,"Skin irritation","Skin irritation","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2014-01-19,2014-02-05,22,39,18,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",87,">80","F",16,"Y"
"CDISCPILOT01","01-716-011",1,"Xanomeline High Dose",2,"Fatigue","Fatigue","General disorders and administration site conditions","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2014-01-23,2014-02-09,24,41,18,"DAY","Y","Y","Y",NA,NA,NA,76,"65-80","M",13,"Y"
"CDISCPILOT01","01-716-013",1,"Xanomeline Low Dose",1,"Syncope","Syncope","Nervous system disorders","GENERAL","MODERATE",2,2,"Y","RELATED","Y",1,2013-12-11,2013-12-12,22,23,2,"DAY","Y","Y","Y","Y",NA,NA,73,"65-80","F",17,"Y"
"CDISCPILOT01","01-716-015",1,"Xanomeline High Dose",2,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-03-06,2013-03-15,22,31,10,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,77,"65-80","F",24,"Y"
"CDISCPILOT01","01-716-019",1,"Placebo",0,"Headache","Headache","Nervous system disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-09-21,2013-10-20,69,98,30,"DAY","Y","Y","Y",NA,NA,NA,75,"65-80","M",20,"Y"
"CDISCPILOT01","01-716-019",2,"Placebo",0,"Nasal congestion","Nasal congestion","Respiratory, thoracic and mediastinal disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-10-04,2013-10-25,82,103,22,"DAY","Y","Y","Y",NA,NA,NA,75,"65-80","M",20,"Y"
"CDISCPILOT01","01-716-021",1,"Placebo",0,"Nasopharyngitis","Nasopharyngitis","Infections and infestations","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-11-27,2014-01-08,19,61,43,"DAY","Y","Y","Y",NA,NA,NA,70,"65-80","F",10,"Y"
"CDISCPILOT01","01-716-022",1,"Xanomeline Low Dose",1,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-08-22,2013-09-02,14,25,12,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,83,">80","F",21,"Y"
"CDISCPILOT01","01-716-024",1,"Xanomeline Low Dose",1,"Application site dermatitis","Application site dermatitis","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-01-14,2013-01-25,4,15,12,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,70,"65-80","M",23,"Y"
"CDISCPILOT01","01-716-024",5,"Xanomeline Low Dose",1,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-03-13,2013-03-30,62,79,18,"DAY","Y","Y","Y",NA,NA,NA,70,"65-80","M",23,"Y"
"CDISCPILOT01","01-716-024",4,"Xanomeline Low Dose",1,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-02-02,2013-02-20,23,41,19,"DAY","Y","Y","Y",NA,NA,NA,70,"65-80","M",23,"Y"
"CDISCPILOT01","01-716-024",2,"Xanomeline Low Dose",1,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-04-04,2013-04-06,84,86,3,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",70,"65-80","M",23,"Y"
"CDISCPILOT01","01-716-024",3,"Xanomeline Low Dose",1,"Rash","Rash","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-05-07,2013-06-17,117,158,42,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",70,"65-80","M",23,"Y"
"CDISCPILOT01","01-716-025",1,"Xanomeline High Dose",2,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-04-14,2013-04-24,47,57,11,"DAY","Y","Y","Y",NA,NA,NA,77,"65-80","F",15,"Y"
"CDISCPILOT01","01-717-002",2,"Xanomeline High Dose",2,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-04-23,2013-05-10,14,31,18,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,74,"65-80","M",21,"Y"
"CDISCPILOT01","01-717-002",1,"Xanomeline High Dose",2,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-04-22,2013-05-08,13,29,17,"DAY","Y","Y",NA,NA,"APPLICATION SITE REACTION",NA,74,"65-80","M",21,"Y"
"CDISCPILOT01","01-717-002",3,"Xanomeline High Dose",2,"Fatigue","Fatigue","General disorders and administration site conditions","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-06-05,2013-06-11,57,63,7,"DAY","Y","Y",NA,NA,NA,NA,74,"65-80","M",21,"Y"
"CDISCPILOT01","01-718-004",2,"Xanomeline High Dose",2,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2014-01-08,2014-01-13,12,17,6,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",79,"65-80","F",20,"Y"
"CDISCPILOT01","01-718-004",1,"Xanomeline High Dose",2,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2014-03-16,2014-04-14,79,108,30,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",79,"65-80","F",20,"Y"
"CDISCPILOT01","01-718-005",1,"Xanomeline Low Dose",1,"Headache","Headache","Nervous system disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-07-08,2013-07-20,29,41,13,"DAY","Y","Y","Y",NA,NA,NA,82,">80","F",19,"Y"
"CDISCPILOT01","01-718-006",2,"Xanomeline High Dose",2,"Agitation","Agitation","Psychiatric disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-06-03,2013-06-06,3,6,4,"DAY","Y","Y","Y",NA,NA,NA,72,"65-80","F",18,"Y"
"CDISCPILOT01","01-718-006",1,"Xanomeline High Dose",2,"Rash","Rash","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-07-23,2013-09-08,53,100,48,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",72,"65-80","F",18,"Y"
"CDISCPILOT01","01-718-007",3,"Xanomeline High Dose",2,"Dizziness","Dizziness","Nervous system disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-11-01,2013-12-13,40,82,43,"DAY","Y","Y","Y",NA,NA,NA,63,"<65","M",20,"Y"
"CDISCPILOT01","01-718-007",2,"Xanomeline High Dose",2,"Hyperhidrosis","Hyperhidrosis","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-10-27,2013-10-31,35,39,5,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",63,"<65","M",20,"Y"
"CDISCPILOT01","01-718-007",5,"Xanomeline High Dose",2,"Myocardial infarction","Myocardial infarction","Cardiac disorders","GENERAL","SEVERE",3,3,"Y","NOT RELATED","N",0,2013-11-22,2013-11-26,61,65,5,"DAY","Y","Y","Y","Y",NA,NA,63,"<65","M",20,"Y"
"CDISCPILOT01","01-718-007",1,"Xanomeline High Dose",2,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-10-04,2013-10-11,12,19,8,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",63,"<65","M",20,"Y"
"CDISCPILOT01","01-718-007",4,"Xanomeline High Dose",2,"Syncope","Syncope","Nervous system disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-10-29,2013-11-15,37,54,18,"DAY","Y","Y",NA,NA,NA,NA,63,"<65","M",20,"Y"
"CDISCPILOT01","01-718-009",1,"Placebo",0,"Upper respiratory tract infection","Upper respiratory tract infection","Infections and infestations","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-04-28,2013-05-05,46,53,8,"DAY","Y","Y","Y",NA,NA,NA,69,"65-80","M",20,"Y"
"CDISCPILOT01","01-718-011",2,"Xanomeline High Dose",2,"Nasal congestion","Nasal congestion","Respiratory, thoracic and mediastinal disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-12-26,2014-01-13,35,53,19,"DAY","Y","Y","Y",NA,NA,NA,72,"65-80","F",23,"Y"
"CDISCPILOT01","01-718-011",1,"Xanomeline High Dose",2,"Sinus bradycardia","Sinus bradycardia","Cardiac disorders","GENERAL","SEVERE",3,3,"Y","POSSIBLY RELATED","Y",1,2013-12-08,2013-12-13,17,22,6,"DAY","Y","Y","Y","Y",NA,NA,72,"65-80","F",23,"Y"
"CDISCPILOT01","01-718-012",1,"Placebo",0,"Application site erythema","Application site erythema","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-12-04,2013-12-17,8,21,14,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,63,"<65","F",14,"Y"
"CDISCPILOT01","01-718-012",2,"Placebo",0,"Hyperhidrosis","Hyperhidrosis","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-12-05,2014-01-12,9,47,39,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",63,"<65","F",14,"Y"
"CDISCPILOT01","01-718-012",3,"Placebo",0,"Insomnia","Insomnia","Psychiatric disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-12-31,2014-01-16,35,51,17,"DAY","Y","Y","Y",NA,NA,NA,63,"<65","F",14,"Y"
"CDISCPILOT01","01-718-012",4,"Placebo",0,"Upper respiratory tract infection","Upper respiratory tract infection","Infections and infestations","GENERAL","LIFE-THREATENING",4,4,"Y","POSSIBLY RELATED","Y",1,2014-02-09,2014-03-09,75,103,29,"DAY","Y","Y","Y","Y",NA,NA,63,"<65","F",14,"Y"
"CDISCPILOT01","01-718-013",3,"Xanomeline Low Dose",1,"Diarrhoea","Diarrhoea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-08-19,2013-09-03,87,102,16,"DAY","Y","Y","Y",NA,NA,NA,74,"65-80","M",23,"Y"
"CDISCPILOT01","01-718-013",1,"Xanomeline Low Dose",1,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-07-23,2013-08-19,60,87,28,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",74,"65-80","M",23,"Y"
"CDISCPILOT01","01-718-013",2,"Xanomeline Low Dose",1,"Nausea","Nausea","Gastrointestinal disorders","GENERAL","MODERATE",2,2,"N","RELATED","Y",1,2013-06-21,2013-07-01,28,38,11,"DAY","Y","Y",NA,NA,NA,NA,74,"65-80","M",23,"Y"
"CDISCPILOT01","01-718-014",1,"Xanomeline Low Dose",1,"Application site irritation","Application site irritation","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-07-14,2013-07-22,9,17,9,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,75,"65-80","M",19,"Y"
"CDISCPILOT01","01-718-016",1,"Xanomeline High Dose",2,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-03-15,2013-03-31,12,28,17,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,69,"65-80","F",10,"Y"
"CDISCPILOT01","01-718-016",2,"Xanomeline High Dose",2,"Nasal congestion","Nasal congestion","Respiratory, thoracic and mediastinal disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-03-27,2013-04-01,24,29,6,"DAY","Y","Y","Y",NA,NA,NA,69,"65-80","F",10,"Y"
"CDISCPILOT01","01-718-016",3,"Xanomeline High Dose",2,"Upper respiratory tract infection","Upper respiratory tract infection","Infections and infestations","GENERAL","SEVERE",3,3,"Y","POSSIBLY RELATED","Y",1,2013-04-09,2013-05-05,37,63,27,"DAY","Y","Y","Y","Y",NA,NA,69,"65-80","F",10,"Y"
"CDISCPILOT01","01-718-017",1,"Placebo",0,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-04-29,2013-05-18,32,51,20,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",67,"65-80","F",24,"Y"
"CDISCPILOT01","01-718-018",1,"Placebo",0,"Insomnia","Insomnia","Psychiatric disorders","GENERAL","MILD",1,1,"N","NOT RELATED","N",0,2013-10-26,2013-11-19,20,44,25,"DAY","Y","Y","Y",NA,NA,NA,88,">80","F",24,"Y"
"CDISCPILOT01","01-718-019",1,"Xanomeline Low Dose",1,"Erythema","Erythema","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-07-09,2013-07-31,45,67,23,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",75,"65-80","F",12,"Y"
"CDISCPILOT01","01-718-019",2,"Xanomeline Low Dose",1,"Skin irritation","Skin irritation","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-07-12,2013-07-18,48,54,7,"DAY","Y","Y",NA,NA,NA,"DERMATOLOGICAL AE",75,"65-80","F",12,"Y"
"CDISCPILOT01","01-718-020",1,"Xanomeline High Dose",2,"Application site irritation","Application site irritation","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-02-27,2013-03-02,21,24,4,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,79,"65-80","F",13,"Y"
"CDISCPILOT01","01-718-020",2,"Xanomeline High Dose",2,"Sinus bradycardia","Sinus bradycardia","Cardiac disorders","GENERAL","MODERATE",2,2,"N","NOT RELATED","N",0,2013-02-14,2013-02-27,8,21,14,"DAY","Y","Y","Y",NA,NA,NA,79,"65-80","F",13,"Y"
"CDISCPILOT01","01-718-021",1,"Xanomeline High Dose",2,"Application site pruritus","Application site pruritus","General disorders and administration site conditions","APPLICATION SITE","MILD",1,1,"N","RELATED","Y",1,2013-09-24,2013-09-26,19,21,3,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,81,">80","M",24,"Y"
"CDISCPILOT01","01-718-021",2,"Xanomeline High Dose",2,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-09-18,2013-10-23,13,48,36,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",81,">80","M",24,"Y"
"CDISCPILOT01","01-718-022",1,"Placebo",0,"Application site dermatitis","Application site dermatitis","General disorders and administration site conditions","APPLICATION SITE","MODERATE",2,2,"N","RELATED","Y",1,2013-10-01,2013-10-01,7,7,1,"DAY","Y","Y","Y",NA,"APPLICATION SITE REACTION",NA,57,"<65","M",13,"Y"
"CDISCPILOT01","01-718-022",4,"Placebo",0,"Fatigue","Fatigue","General disorders and administration site conditions","GENERAL","MILD",1,1,"N","RELATED","Y",1,2013-11-07,2013-11-14,44,51,8,"DAY","Y","Y",NA,NA,NA,NA,57,"<65","M",13,"Y"
"CDISCPILOT01","01-718-022",3,"Placebo",0,"Myocardial infarction","Myocardial infarction","Cardiac disorders","GENERAL","MODERATE",2,2,"N","POSSIBLY RELATED","Y",1,2013-09-30,2013-10-25,6,31,26,"DAY","Y","Y","Y",NA,NA,NA,57,"<65","M",13,"Y"
"CDISCPILOT01","01-718-022",2,"Placebo",0,"Pruritus","Pruritus","Skin and subcutaneous tissue disorders","GENERAL","MILD",1,1,"N","POSSIBLY RELATED","Y",1,2013-11-21,2013-12-26,58,93,36,"DAY","Y","Y","Y",NA,NA,"DERMATOLOGICAL AE",57,"<65","M",13,"Y"
